home / stock / aray / aray news


ARAY News and Press, Accuray Incorporated From 06/26/23

Stock Information

Company Name: Accuray Incorporated
Stock Symbol: ARAY
Market: NASDAQ
Website: accuray.com

Menu

ARAY ARAY Quote ARAY Short ARAY News ARAY Articles ARAY Message Board
Get ARAY Alerts

News, Short Squeeze, Breakout and More Instantly...

ARAY - Accuray to be included in Russell 2000 and Russell 3000 indexes

2023-06-26 08:03:55 ET Radiosurgery and radiation therapy systems company Accuray ( NASDAQ: ARAY ) said on Monday that it will be included in the Russell 2000 index and the broad-market Russell 3000 index, effective today. The addition is a part of the annual reconstitution of...

ARAY - Accuray Incorporated Announces Its Addition to the Russell 2000® Index

Accuray Incorporated Announces Its Addition to the Russell 2000® Index PR Newswire SUNNYVALE, Calif. , June 26, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that as part of the annual reconstitution of the Russell stock indexes, t...

ARAY - Cognizant is Partnering with Accuray to Accelerate Corporate Transformation and Drive Operational Efficiency in Their Radiation Therapy Business

Cognizant is Partnering with Accuray to Accelerate Corporate Transformation and Drive Operational Efficiency in Their Radiation Therapy Business PR Newswire Partnership Will Support Accuray with SAP S/4HANA Implementation TEANECK, N.J. , June 21, 2023 /PR...

ARAY - Accuray Announces Suzanne Winter Selected as One of the Top 50 Healthcare Technology CEOs of 2023

Accuray Announces Suzanne Winter Selected as One of the Top 50 Healthcare Technology CEOs of 2023 PR Newswire SUNNYVALE, Calif. , June 15, 2023 /PRNewswire/ -- The global Accuray Incorporated (NASDAQ: ARAY) team is proud to announce that president and CEO ...

ARAY - Accuray CyberKnife® and TomoTherapy® Platforms Featured in More Than 55 Abstracts Presented at ESTRO 2023, Reinforcing Systems' Versatility, Efficiency and Effectiveness

Accuray CyberKnife® and TomoTherapy® Platforms Featured in More Than 55 Abstracts Presented at ESTRO 2023, Reinforcing Systems' Versatility, Efficiency and Effectiveness PR Newswire Data Highlight Expanding Use of (Ultra) Hypofractionated Treatments, Benefits in Pati...

ARAY - Accuray Stays On Track, But Ramping In China Remains A Key Future Driver

2023-04-29 03:01:22 ET Summary Accuray had a respectable fiscal third quarter with better-than-expected revenue driven by another quarter of good system placements, including share gains in the Japanese market. Supply chain challenges continue to pressure margins, and orders are s...

ARAY - Why Shares of Accuray Rose Thursday

2023-04-27 13:35:26 ET Shares of Accuray (NASDAQ: ARAY) were up by more than 15% early Thursday afternoon after the healthcare company released its fiscal 2023 third-quarter earnings Wednesday afternoon. The radiation oncology device specialist makes the CyberKnife and Tomo Ther...

ARAY - ContraFect, Accuray top healthcare gainers; Baudax, 4D Molecular among losers

2023-04-27 10:01:57 ET Gainers: ContraFect ( CFRX ) +112% . Accuray ( ARAY ) +14% . Mainz Biomed ( MYNZ ) +15% . Mangoceuticals ( MGRX ) +14% . Immix Biopharma ( IMMX ) +9% . Losers: Baudax Bio ( BXRX ) -52% ....

ARAY - Accuray Incorporated (ARAY) Q3 2023 Earnings Call Transcript

2023-04-26 21:15:06 ET Accuray Incorporated (ARAY) Q3 2023 Earnings Conference Call April 26, 2023 4:30 PM ET Company Participants Jesse Chew – Chief Legal Officer Suzanne Winter – President and Chief Executive Officer Ali Pervaiz – Chief Fin...

ARAY - Accuray GAAP EPS of $0.01 beats by $0.02, revenue of $118.1M beats by $8.32M, guidance in-line

2023-04-26 16:13:27 ET Accuray press release ( NASDAQ: ARAY ): FQ3 GAAP EPS of $0.01 beats by $0.02 . Revenue of $118.1M (+22.8% Y/Y) beats by $8.32M . Total revenue is expected in the range of $447.0 million to $455.0 million, vs. consensus of $449.71M, r...

Previous 10 Next 10